Global Functional Genomics Market Size study, by Product, by Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies), by Application, by End-User and Regional Forecasts 2022-2032

Description

Global Functional Genomics Market was valued at USD 9.54 billion in 2023 and is anticipated to project robust growth in the forecast period with a compound annual growth rate (CAGR) of 9.25% through 2029. Functional genomics, a rapidly advancing sector within the biotechnology field, focuses on the systematic study of gene functions and interactions within an organism. This discipline is pivotal for understanding the underlying mechanisms of diseases, thus driving significant growth in the market. The expansion of the functional genomics market is propelled by the rising prevalence of genetic disorders, cancer, and infectious diseases, which in turn, increases the demand for advanced research and development activities. Also, technological innovations such as CRISPR-Cas9, RNA interference, and next-generation sequencing (NGS) are crucial in functional genomics studies, enabling precise gene editing and comprehensive analysis of gene expression patterns. These technologies facilitate groundbreaking research and offer new possibilities in personalized medicine, significantly contributing to market growth. Pharmaceutical and biotechnology companies are major players in this domain, investing heavily in cutting-edge technologies to discover novel drug targets and develop personalized therapeutic interventions. The integration of artificial intelligence (AI) and big data analytics further enhances the efficiency of functional genomics research, opening new avenues for understanding, diagnosing, and treating various genetic conditions.

The rising demand for technological advancements is a key driver of market growth. Innovations in genomic sequencing technologies, notably NGS, have revolutionized genomic analysis by improving speed, accuracy, and cost-effectiveness. These advancements have democratized functional genomics, enabling large-scale genomic sequencing and broader adoption of genomic research. Additionally, recent developments in single-cell genomics have expanded the scope of functional genomics, allowing for detailed insights into cellular heterogeneity and the complexity of biological systems. The integration of big data analytics and bioinformatics is another significant growth driver. These fields provide essential tools for managing and analyzing the vast and intricate genomic data sets generated by functional genomics. The use of advanced computational tools and visualization techniques enables researchers to derive actionable insights from genomic data, driving the discovery of potential diagnostic or prognostic biomarkers and contributing to the development of personalized treatment strategies. However, the market faces challenges related to data privacy and security. The sensitive nature of genomic information necessitates robust frameworks to prevent unauthorized access and misuse. Establishing global standards for data privacy and security, along with advancements in encryption technologies, is crucial for maintaining public trust and ethical standards in genomic research.

North America currently dominates the global functional genomics market, supported by a robust research infrastructure, extensive funding, and a high concentration of leading biotechnology and pharmaceutical companies. The region's leadership is further bolstered by supportive government initiatives, a skilled workforce, and collaborations between academia and industry. The presence of advanced technologies and a favourable regulatory environment positions North America as a focal point for cutting-edge research and innovation in functional genomics.

Major market players included in this report are:

Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation (Integrated DNA Technologies, Inc.)
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
MRM Proteomics Inc
Perkin Elmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product:

Kits Assays
Instruments

By Technology:

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Other Technologies

By Application:

Epigenomics
Transcriptomics
Proteomics
Metabolomics

By End-User:

Academic and Research Institutions
Biotechnology and Biopharmaceutical Companies
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Functional Genomics Market Executive Summary

1.1. Global Functional Genomics Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Technology
- 1.3.3. By Application
- 1.3.4. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Functional Genomics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Functional Genomics Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Demand for Technological Advancements
- 3.1.2. Growing Awareness for Data Analytics and Bioinformatics
- 3.1.3. Growing Interest in Data Visualization and Data Interpretation
3.2. Market Challenges
- 3.2.1. Data Privacy and Security
3.3. Market Opportunities
- 3.3.1. Advancements in Single-Cell Genomics
- 3.3.2. Integration of AI and Big Data Analytics

Chapter 4. Global Functional Genomics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Functional Genomics Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Functional Genomics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Kits Assays
- 5.2.2. Instruments

Chapter 6. Global Functional Genomics Market Size & Forecasts by Technology 2022-2032

6.1. Segment Dashboard
6.2. Global Functional Genomics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Next-Generation Sequencing (NGS)
- 6.2.2. Polymerase Chain Reaction (PCR)
- 6.2.3. Microarray
- 6.2.4. Other Technologies

Chapter 7. Global Functional Genomics Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Functional Genomics Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Epigenomics
- 7.2.2. Transcriptomics
- 7.2.3. Proteomics
- 7.2.4. Metabolomics

Chapter 8. Global Functional Genomics Market Size & Forecasts by End-User 2022-2032

8.1. Segment Dashboard
8.2. Global Functional Genomics Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Academic and Research Institutions
- 8.2.2. Biotechnology and Biopharmaceutical Companies
- 8.2.3. Others

Chapter 9. Global Functional Genomics Market Size & Forecasts by Region 2022-2032

9.1. North America Functional Genomics Market
- 9.1.1. U.S. Functional Genomics Market
  - 9.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Technology breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Application breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End-User breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Functional Genomics Market
9.2. Europe Functional Genomics Market
- 9.2.1. U.K. Functional Genomics Market
- 9.2.2. Germany Functional Genomics Market
- 9.2.3. France Functional Genomics Market
- 9.2.4. Spain Functional Genomics Market
- 9.2.5. Italy Functional Genomics Market
- 9.2.6. Rest of Europe Functional Genomics Market
9.3. Asia-Pacific Functional Genomics Market
- 9.3.1. China Functional Genomics Market
- 9.3.2. India Functional Genomics Market
- 9.3.3. Japan Functional Genomics Market
- 9.3.4. Australia Functional Genomics Market
- 9.3.5. South Korea Functional Genomics Market
- 9.3.6. Rest of Asia Pacific Functional Genomics Market
9.4. Latin America Functional Genomics Market
- 9.4.1. Brazil Functional Genomics Market
- 9.4.2. Mexico Functional Genomics Market
- 9.4.3. Rest of Latin America Functional Genomics Market
9.5. Middle East & Africa Functional Genomics Market
- 9.5.1. Saudi Arabia Functional Genomics Market
- 9.5.2. South Africa Functional Genomics Market
- 9.5.3. Rest of Middle East & Africa Functional Genomics Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Agilent Technologies, Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Becton, Dickinson and Company
- 10.3.3. Bio-Rad Laboratories, Inc.
- 10.3.4. Danaher Corporation (Integrated DNA Technologies, Inc.)
- 10.3.5. F. Hoffmann-La Roche Ltd.
- 10.3.6. Illumina, Inc.
- 10.3.7. MRM Proteomics Inc
- 10.3.8. Perkin Elmer, Inc.
- 10.3.9. QIAGEN N.V.
- 10.3.10. Thermo Fisher Scientific, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes